MeSH term
Frequency | Condition_Probility | Animals | 6 | 0.0 |
Male | 4 | 0.0 |
Mice | 4 | 0.0 |
Phenotype | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 14 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Humans | 15 | 0.0 |
Phosphorylation | 2 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 2 | 0.0 |
Cell Line | 2 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
*Dosage Compensation (Genetics) | 2 | 1.0 |
Female | 5 | 0.0 |
Hybrid Cells | 4 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
X Chromosome/*genetics | 2 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Pedigree | 2 | 0.0 |
*X Chromosome | 5 | 0.0 |
Blotting, Northern | 2 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
Molecular Sequence Data | 5 | 0.0 |
Transcription, Genetic/*genetics | 2 | 1.0 |
Base Sequence | 3 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Proteoglycans/*genetics | 5 | 8.0 |
Blotting, Southern | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Mutation | 3 | 0.0 |
Pregnancy | 2 | 0.0 |
Genes, Reporter | 2 | 0.0 |
Genetic Vectors | 2 | 0.0 |
Immunoblotting | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Transfection | 2 | 0.0 |
Transforming Growth Factor beta/*metabolism | 2 | 0.0 |
Up-Regulation | 2 | 0.0 |
